Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Zvi Yammer who wrote (891)	11/2/1997 12:46:00 PM
From: Steve Harmon	Read Replies (1) \| Respond to of 2742

To all CIST shareholders, FACT: Bluestone Capital's contract with CIST ends within 4 months. CIST has paid up. Bluestone should be paying up SOON. REMEMBER: CIST's mgt. could easily eliminate the over hang(CLOUD) on Monday if they wanted to INCREASE shareholder value.

To: Zvi Yammer who wrote (891)	11/2/1997 8:44:00 PM
From: John Metcalf	Respond to of 2742

Hello, Zvi (Y). You're not being argumentative and I appreciate your thoughts on this. I understand why people infer that selling is going on. In fact, I've maintained a record of the daily activity in Cistron stock for over a year, in order to confirm/deny the likelihood of such conjectures. As I've said several times here, the stories of various parties selling their shares on the market have not been reflected in facts. I'm one of the odd ducks who reads the 10-K. The latest one says CIST has $6,368,228 in cash and equivalents and 26,884,990 shares outstanding. That's just under $.24 per share. The trade record I maintain tells me that no one is willing to sell below the cash value of the company. Sometime this month, they'll receive another $3mm from Immunex, and then we'll know whether anyone is willing to sell below the new cash value. As to the BlueStone agreement, which is renewable should it lapse in four months, the 10-K also points to the objects of it: "The Company would be obligated to make payments including certain percentage fees as well as to issue additional warrants to BlueStone to purchase up to an additional 400,000 shares should BlueStone assist Cistron in completing a merger, acquisition, joint venture, partnership, license or contract."